Show simple item record

dc.contributor.editorLouis, Irina Vlasova-St.
dc.date.accessioned2023-09-05T16:01:27Z
dc.date.available2023-09-05T16:01:27Z
dc.date.issued2023
dc.identifierONIX_20230905_9781803556581_171
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/113370
dc.description.abstractRNA therapies evolved as economical and widely applicable individualized treatment solutions. Novel RNA-based therapeutic vaccines (e.g., against SARS-CoV-2 infection) have been proven to be safe and effective, and many of them are approved by the United States Food and Drug Administration (FDA). This book presents distinct classes of RNA therapeutics, ranging from single-stranded antisense oligonucleotides (ASOs) and subclasses of RNA interferences (miRNAs and other RNAi) to in vitro transcribed and in vivo translated mRNAs drugs and RNA vaccines. The book also discusses some of the challenges in RNA drug engineering, delivery, and specificity, as well as highlights the improvement of pharmacological effectiveness in a wide range of diseases.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSD Molecular biologyen_US
dc.subject.othercancer
dc.subject.otherclinical trials
dc.subject.othercovid-19
dc.subject.otherpandemic
dc.subject.othersars-cov-2
dc.subject.otherpublic health
dc.titleRNA Therapeutics
dc.title.alternativeHistory, Design, Manufacturing, and Applications
dc.typebook
oapen.identifier.doi10.5772/intechopen.102166
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9781803556581
oapen.relation.isbn9781803556574
oapen.relation.isbn9781803556598
oapen.imprintIntechOpen
oapen.pages138


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/3.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/3.0/